Evidence map›Paper›PMID 35052700›Full record

ArticleBiomedicines2021

Amyloid Precursor Protein A713T Mutation in Calabrian Patients with Alzheimer's Disease: A Population Genomics Approach to Estimate Inheritance from a Common Ancestor.

Paolo Abondio, Stefania Sarno, Cristina Giuliani, Valentina Laganà, Raffaele Maletta, Livia Bernardi, Francesco Bruno, Rosanna Colao, Gianfranco Puccio, Francesca Frangipane and 4 more

Abstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. The Nerve Growth Factor Receptor (NGFR/p75International journal of molecular sciences · 2023
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Paolo AbondioLaboratory of Molecular Anthropology, Center for Genome Biology, Department of Biological, Geological and Environmental Sciences, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-9626-8495
Stefania SarnoLaboratory of Molecular Anthropology, Center for Genome Biology, Department of Biological, Geological and Environmental Sciences, University of Bologna, 40126 Bologna, Italy.
Cristina GiulianiLaboratory of Molecular Anthropology, Center for Genome Biology, Department of Biological, Geological and Environmental Sciences, University of Bologna, 40126 Bologna, Italy.
Valentina LaganàRegional Neurogenetic Center, Azianda Sanitaria Provinciale Catanzaro, 88046 Lamezia Terme, Italy.
Raffaele MalettaRegional Neurogenetic Center, Azianda Sanitaria Provinciale Catanzaro, 88046 Lamezia Terme, Italy.
Livia BernardiRegional Neurogenetic Center, Azianda Sanitaria Provinciale Catanzaro, 88046 Lamezia Terme, Italy.
Francesco BrunoRegional Neurogenetic Center, Azianda Sanitaria Provinciale Catanzaro, 88046 Lamezia Terme, Italy.
Rosanna ColaoRegional Neurogenetic Center, Azianda Sanitaria Provinciale Catanzaro, 88046 Lamezia Terme, Italy.
Gianfranco PuccioRegional Neurogenetic Center, Azianda Sanitaria Provinciale Catanzaro, 88046 Lamezia Terme, Italy.
Francesca FrangipaneRegional Neurogenetic Center, Azianda Sanitaria Provinciale Catanzaro, 88046 Lamezia Terme, Italy.
Barbara BorroniDepartment of Neurology, University of Brescia, 25121 Brescia, Italy.
Christine Van BroeckhovenNeurodegenerative Brain Diseases Group, Center for Molecular Neurology, Vlaams Instituut voor Biotechnologie, 2600 Antwerp, Belgium.ORCID 0000-0003-0183-7665
Donata LuiselliAncient DNA Laboratory, Department of Cultural Heritage, Ravenna Campus, University of Bologna, 48121 Ravenna, Italy.ORCID 0000-0003-2105-2478
Amalia BruniRegional Neurogenetic Center, Azianda Sanitaria Provinciale Catanzaro, 88046 Lamezia Terme, Italy.

Funding

Ministry of Education, Universities and Research PRIN 20177PJ9XF
6 · The paper itself

Abstract

Mutation A713T in the amyloid precursor protein (APP) has been linked to cases of Alzheimer's disease (AD), cerebral amyloid angiopathy (CAA) and cerebrovascular disease. Despite its rarity, it has been observed in several families from the same geographical area, in the Calabria region in Southern Italy. Genotyping of 720,000 genome-wide SNPs with the HumanOmniExpress BeadChip was performed for six patients that were representative of apparently unrelated Calabrian families, as well as a Belgian subject of Italian descent (all with the same A713T mutation and disease). Their genomic structure and genetic relationships were analyzed. Demographic reconstruction and coalescent theory were applied to estimate the time of the most recent common ancestor (tMRCA) among patients. Results show that all A713T carriers fell into the genetic variability of Southern Italy and were not more closely related to each other than to any other healthy Calabrian individual. However, five out of seven patients shared a 1.7 Mbp-long DNA segment centered on the A713T mutation, making it possible to estimate a tMRCA for its common origin in the Calabrian region dating back over 1000 years. The analysis of affected individuals with methodologies based on human population genomics thus provides informative insights in support of clinical observations and biomedical research.

Indexed as

A713TAlzheimer’s diseaseamyloidAPPcommon ancestorgeneticsneurodegenerationpopulation genomics

Identifiers

PMID35052700
PMCPMC8773445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.